NDC 61958-2002 – Descovy
Emtricitabine 200 mg/1; Tenofovir Alafenamide Fumarate 25 mg/1 · Tablet · Oral
Product NDC61958-2002
Product details
- Brand name
- Descovy
- Generic name
- Emtricitabine and tenofovir alafenamide
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA208215
- Marketed since
- April 4, 2016
- Listing expires
- December 31, 2027
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Emtricitabine 200 mg/1
- Tenofovir Alafenamide Fumarate 25 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 61958-2002-1 | 30 TABLET in 1 BOTTLE, PLASTIC (61958-2002-1) | Apr 4, 2016 |
| 61958-2002-2 | 30 TABLET in 1 BLISTER PACK (61958-2002-2) | Jan 22, 2020 |
Other Descovy products
- 61958-2005 Emtricitabine 120 mg/1; Tenofovir Alafenamide Fumarate 15 mg/1 · Tablet · Gilead Sciences, Inc.